Predischarge Prediction of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Derivation and Validation of a Risk Prediction Score.
Caroline J RieserLauren B HallEliza KangAmer H ZureikatMatthew P HoltzmanJames F PingpankDavid L BartlettM Haroon A ChoudryPublished in: Annals of surgical oncology (2021)
Our proposed risk score, easily obtainable on day of discharge, distinguishes patients at high risk for readmission over 90 days following CRS/HIPEC. This score has the potential to target high-risk individuals for intensive follow-up and other interventions.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- minimally invasive
- newly diagnosed
- peritoneal dialysis
- physical activity
- prognostic factors
- squamous cell carcinoma
- coronary artery bypass
- locally advanced
- patient reported outcomes
- acute coronary syndrome
- risk assessment
- atrial fibrillation
- percutaneous coronary intervention